Clinical Trial Update: Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating tolerability, safety, and pharmacokinetics of GX-30 in adults undergoing total or near-total thyroidectomy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Near-total Thyroidectomy
• Total Thyroidectomy

Drugs mentioned

• GX-30

Snippet

Sponsor: Genexine, Inc. | Conditions: Total Thyroidectomy, Near-total Thyroidectomy | Phase 1, Phase 2 | Status: COMPLETED